A comparison of the prognosticators identified for tongue and laryngopharynx indicated that AP2M1 and IGF2BP2 are common across sites, with deregulation of AP2M1, a protein trafficking molecule, signifying contradictory effects in tongue and laryngeal cancer. The gene discussed is IGF2BP2; the disease is laryngeal carcinoma.